Sean M. Devlin

19.4k citations

269 papers · 4.0k indexed · 1 hit paper · h-index 33

Impact in

Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in ⓘ

Hematology 165
- Hematopoietic Stem Cell Transplantation 83
- Acute Myeloid Leukemia Research 64
- Multiple Myeloma Research and Treatments 49
- Chronic Myeloid Leukemia Treatments 22
Transplantation 22
- Renal Transplantation Outcomes and Treatments 22

Co-authors: Sergio Giralt (135 shared papers)Martin S. Tallman (31 shared papers)Miguel‐Angel Perales (96 shared papers)Craig S. Sauter (49 shared papers)Ross L. Levine (18 shared papers)Ola Landgren (28 shared papers)Maria E. Arcila (14 shared papers)Ahmet Zehir (7 shared papers)
Journals: Blood (92 papers)Biology of Blood and Marrow Transplantation (56 papers)Bone Marrow Transplantation (16 papers)Blood Advances (14 papers)Transplantation and Cellular Therapy (14 papers)
Partner nations: United States Spain Canada

In The Last Decade

Sean M. Devlin

244 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes 2017 · 521 citations

Peers

Countries citing papers authored by Sean M. Devlin

Since Specialization

Citations

This map shows the geographic impact of Sean M. Devlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean M. Devlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean M. Devlin more than expected).

Fields of papers citing papers by Sean M. Devlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean M. Devlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean M. Devlin. The network helps show where Sean M. Devlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Sean M. Devlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sean M. Devlin Line = papers co-authored together Sean M. Devlin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 269 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes Cell stem cell ·Catherine C. Coombs, Ahmet Zehir, Sean M. Devlin, Ashwin Kishtagari, Aijazuddin Syed, Philip Jonsson, David M. Hyman, David B. Solit, Mark E. Robson, José Baselga, Maria E. Arcila, Marc Ladanyi, Martin S. Tallman, Ross L. Levine, Michael F. Berger Hit paper breakdown →	2017	521
2	Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma Blood Cancer Journal ·Kitsada Wudhikarn, M. Lia Palomba, Martina Pennisi, Marta García‐Recio, Jessica Flynn, Sean M. Devlin, Aishat Olaide Afuye, Mari Lynne Silverberg, Molly Maloy, Gunjan L. Shah, Michael Scordo, Parastoo B. Dahi, Craig S. Sauter, Connie Lee Batlevi, Bianca Santomasso, Elena Mead, Susan K. Seo, Miguel‐Angel Perales	2020	161
3	T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy Cancer Immunology Research ·David J. Chung, Katherine B. Pronschinske, Justin A. Shyer, Sneh Sharma, Samantha Leung, Shane A. Curran, Alexander M. Lesokhin, Sean M. Devlin, Sergio Giralt, James W. Young	2015	147
4	Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation Blood ·Miguel‐Angel Perales, Jeffrey L. Goldberg, Jianda Yuan, Guenther Koehne, Lauren Lechner, Esperanza B. Papadopoulos, James W. Young, Ann A. Jakubowski, Bushra Zaidi, Humilidad F. Gallardo, Cailian Liu, Teresa Rasalan, Jedd D. Wolchok, Thérèse Croughs, Michel Morre, Sean M. Devlin, Marcel R.M. van den Brink	2012	140
5	Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis Bone Marrow Transplantation ·Ola Landgren, Sean M. Devlin, Mathieu Boulad, Sham Mailankody	2016	137
6	CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results Nature Medicine ·Jae H. Park, Karthik Nath, Sean M. Devlin, Craig S. Sauter, M. Lia Palomba, Gunjan L. Shah, Parastoo B. Dahi, Richard J. Lin, Michael Scordo, Miguel‐Angel Perales, Roni Shouval, Ana Alarcón Tomás, Elizabeth Cathcart, Elena Mead, Bianca Santomasso, Andrei I. Holodny, Renier J. Brentjens, Isabelle Rivière, Michel Sadelain	2023	99
7	Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation Biology of Blood and Marrow Transplantation ·Bartlomiej Getta, Sean M. Devlin, Ross L. Levine, Maria E. Arcila, Abhinita Mohanty, Ahmet Zehir, Martin S. Tallman, Sergio Giralt, Mikhail Roshal	2017	97
8	Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma Blood ·Craig S. Sauter, Matthew J. Matasar, Jessica Meikle, Heiko Schöder, Gary A. Ulaner, Jocelyn Migliacci, Patrick Hilden, Sean M. Devlin, Andrew D. Zelenetz, Craig H. Moskowitz	2015	89
9	DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality Blood Advances ·Kitsada Wudhikarn, Martina Pennisi, Marta García‐Recio, Jessica Flynn, Aishat Olaide Afuye, Mari Lynne Silverberg, Molly Maloy, Sean M. Devlin, Connie Lee Batlevi, Gunjan L. Shah, Michael Scordo, Maria Lia Palomba, Parastoo B. Dahi, Craig S. Sauter, Bianca Santomasso, Elena Mead, Miguel‐Angel Perales	2020	85
10	Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL JCI Insight ·Mark B. Geyer, Isabelle Rivière, Brigitte Sénéchal, Xiuyan Wang, Yongzeng Wang, Terence J. Purdon, Meier Hsu, Sean M. Devlin, M. Lia Palomba, Elizabeth Halton, Yvette Bernal, Dayenne G. van Leeuwen, Michel Sadelain, Jae H. Park, Renier J. Brentjens	2019	69
11	Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors Blood ·Andrew Dunbar, Kelly L. Bolton, Sean M. Devlin, Francisco Sánchez-Vega, Jianjiong Gao, Jodi V. Mones, Jonathan Wills, Daniel J. Kelly, Mirko Farina, Keith B. Cordner, Young Joo Park, Sirish Kishore, Krishna Juluru, Neil M. Iyengar, Ross L. Levine, Ahmet Zehir, Wungki Park, Alok A. Khorana, Gerald A. Soff, Simon Mantha	2020	66
12	A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma Blood ·Nikoletta Lendvai, Patrick Hilden, Sean M. Devlin, Heather Landau, Hani Hassoun, Alexander M. Lesokhin, Ioanna Tsakos, Kaitlyn Redling, Guenther Koehne, David J. Chung, Wendy Schaffer, Sergio Giralt	2014	65
13	Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia Journal of Clinical Oncology ·Gerald A. Soff, Yimei Miao, Gemma Bendheim, Jeanette Batista, Jodi V. Mones, Rekha Parameswaran, Cy R. Wilkins, Sean M. Devlin, Ghassan K. Abou‐Alfa, Andrea Cercek, Nancy E. Kemeny, Debra Sarasohn, Simon Mantha	2019	63
14	Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis Blood Advances ·Juliet N. Barker, Kirsten M Boughan, Parastoo B. Dahi, Sean M. Devlin, Molly Maloy, Kristine Naputo, Christopher Mazis, Eric Davis, Melissa Nhaissi, Deborah Wells, Candice Cooper, Doris M. Ponce, Nancy A. Kernan, Andromachi Scaradavou, Sergio Giralt, Esperanza B. Papadopoulos, Ioannis Politikos	2019	63
15	Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based Therapy Molecular Therapy ·Mark B. Geyer, Isabelle Rivière, Brigitte Sénéchal, Xiuyan Wang, Yongzeng Wang, Terence J. Purdon, Meier Hsu, Sean M. Devlin, Elizabeth Halton, Nicole Lamanna, Jürgen Rademaker, Michel Sadelain, Renier J. Brentjens, Jae H. Park	2018	60
16	Romiplostim for management of chemotherapy-induced thrombocytopenia Supportive Care in Cancer ·Rekha Parameswaran, Matthew A. Lunning, Simon Mantha, Sean M. Devlin, Amy L. Hamilton, Gary G. Schwartz, Gerald A. Soff	2014	58
17	A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL Blood ·Craig S. Sauter, Matthew J. Matasar, Heiko Schöder, Sean M. Devlin, Pamela Drullinsky, John F. Gerecitano, Anita Kumar, Ariela Noy, Maria Lia Palomba, Carol S. Portlock, David J. Straus, Andrew D. Zelenetz, Susan J. McCall, Shoshana T. Miller, Amanda I. Courtien, Anas Younes, Craig H. Moskowitz	2018	49
18	A Novel Reduced-Intensity Conditioning Regimen Induces a High Incidence of Sustained Donor-Derived Neutrophil and Platelet Engraftment after Double-Unit Cord Blood Transplantation Biology of Blood and Marrow Transplantation ·Doris M. Ponce, Craig S. Sauter, Sean M. Devlin, Marissa Lubin, Anne Marie Gonzales, Nancy A. Kernan, Andromachi Scaradavou, Sergio Giralt, Jenna D. Goldberg, Guenther Koehne, Miguel‐Angel Perales, James W. Young, Hugo Castro‐Malaspina, Ann A. Jakubowski, Esperanza B. Papadopoulos, Juliet N. Barker	2013	48
19	Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition Blood Advances ·Matthew J. Pianko, Sean M. Devlin, Eric R. Littmann, Aisara Chansakul, Donna Mastey, Meghan Salcedo, Emily Fontana, Lilan Ling, Elizabet Tavitian, John Slingerland, Ann E. Slingerland, Annelie Clurman, Antonio L. C. Gomes, Ying Taur, Eric G. Pamer, Jonathan U. Peled, Marcel R.M. van den Brink, Ola Landgren, Alexander M. Lesokhin	2019	47
20	Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia Annals of Hematology ·Samantha Reiss, Larry W. Buie, Nelly G. Adel, Debra A. Goldman, Sean M. Devlin, Dan Douer	2016	47

About Sean M. Devlin

Sean M. Devlin is a scholar working on Hematology, Transplantation, Genetics, Internal Medicine and Oncology, having authored 269 papers that have together received 4.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (83 papers), Acute Myeloid Leukemia Research (64 papers), Multiple Myeloma Research and Treatments (49 papers), Acute Lymphoblastic Leukemia research (36 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (22 papers) and Renal Transplantation Outcomes and Treatments (22 papers). The work is most often cited by research in Hematology (2.1k citations), Genetics (770 citations), Oncology (1.6k citations), Transplantation (112 citations) and Immunology (624 citations). Sean M. Devlin has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Sergio Giralt, Martin S. Tallman, Miguel‐Angel Perales, Craig S. Sauter, Ross L. Levine, Ola Landgren, Maria E. Arcila, Ahmet Zehir, Molly Maloy and David J. Chung. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, Blood Advances and Transplantation and Cellular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact